Antifungals Flashcards
Yeasts
Candida
Cryptococcus
Dimorphic fungi
Coccidioides
Blastomyces
Histoplasma
Paracoccidiodes
Moulds
Aspergillus
Zygomycetes
Fusarium
Scedosporium
Polyenes
Amphotericin B
Topical nystatin
Main toxicity of amphotericin B
Nephrotoxicity
Infusion-related Rxns
Ampho. B MOA
Polyenes bind to the ergosterol in the cell membrane of fungi, disrupting its membrane
ABCD
Ampho. B colloidal dispersion
ABLC
Ampho. B lipid complex
LAmB, Ambisome
Liposomal amphotericin B
Spectrum for Polyenes
Good for everything except candida lusitaniae
Polyene AEs
Nephrotoxicity
Infusion-related reactions (use APAP or benadryl)
Electrolyte disturbances (decreased Mg/Ca, increase/decrease K)
Amphotericin dosing problems
-Many formulations can lead to dosing confusion
Ampho. B deoxycholate is 0.5-1.5mg/kg/d and lipid formulations are 3-6mg/kg/d
What is given to treat rigors with amphotericin B
Meperidine
Utility of Polyenes
DOC for cryptococcal meningitis (and serious forms of other fungal infections, such as dimorphic fungi and some mould infections)
Drug interactions with amphotericin
Increased nephrotoxicity with other nephrotoxic agents (aminoglycosides, CsA, etc)
Antimetabolits
Flucytosine (5-FC) is the only drug in this class
5-FC spectrum
in combination with amphotericin B: cryptococcus neoformans, most species of candida
5-FC MOA
Antimetabolite that interferes with DNA synthesis; enters fungal cell -> converts to floururacil -> competes with uracil -> interferes with fungal RNA and protein synthesis
5-FC AEs
Relatively selective for fungi
Can cause bone marrow suppression, esp in high doses for long periods of time
Can cause GI disturbances and CNS effects (HA, confusion, atacia, hallucinations)
5-FC important facts
Drug concentration monitoring usually done off site.
Check peak about 2 hours after a dose is given
Do not rely on concentrations alone
Dose adjustments need for renal insufficiency
Drug interactions for 5-FC
Increased effect with amphotericin B
5-FC utility
Tx of cryptococcal disease in combo with Ampho. B
5-FC Don’t Forget
Follow CBC closely
Azoles
Itraconazole Fluconazole Voriconazole Posaconazole Isavuconazole
Azole MOA
Inhibit fungal CYP450, decreasing ergosterol production
Itraconazole good spectrum
C. albicans C. tropicalis C. parasilosis C. lusitaniae Cryptococcus neoformans Aspergillus Many dimorphic fungi
Itraconazole Moderate spectrum
C. glabrata
C. Krusei
Itraconazole Poor spectrum
Mucorales (zygomycetes spp.), other moulds
Fluconazole Good spectrum
C. albicans C. tropicalis C. parasilosis Cryptococcus neoformans Coccidiodes immitis
Voriconazole Good spectrum
C. albicans C. tropicalis C. parasilosis C. lusitaniae C. krusei Aspergillus spp.** Many other moulds
Fluconazole moderate spectrum
C. glabrata
Fluconazole poor spectrum
Moulds
Dimorphic fungi
C. krusei
Voriconazole Moderate spectrum
C. glabrata & C. albicans (that are fluconazole resistant)
Fusarium spp.
Voriconazole poor spectrum
Mucorales (zygomycetes spp.)
Posaconazole good spectrum
C. albicans C. tropicalis C. parasilosis C. lusitaniae C. krusei Aspergillus** Mucorales (Zygomycetes spp)*** Many moulds Dimorphic fungi***
Posaconazole moderate spectrum
C. glabrata
Fusarium spp.
Isavuconazole good spectrum
Candida spp.
Aspergillus spp. ***
Mucorales (Zygomycetes spp.)
Other moulds, dimorphic fungi
Isavuconazole moderate spectrum
C. glabrata
Isavuconazole poor spectrum
Fusarium
Itraconazole AEs
Hepatotoxicity
QTc prolongation
Contraindicated with HF
Itraconazole DDIs
Strong CYP3A4 inhibitor
Itraconazole important facts
Lower F than the solution and are less preferred for systemic fungal infections
Capsules always be taken with food
Solution taken on empty stomach
Absorption inhibited by PPIs
Itraconazole utility
DOC for some dimorphic infxns, such as histoplasmosis
Fluconazole AEs
Can cause hepatotoxicity or rash
QTc prolongation
Fluconazole DDIs
Lower propensity for drug interactions
Strong inhibitor of CYP 2C9 and 2C19
Moderate inhibitor of CYP 3A4
Fluconazole Important facts
Adjust dose based on renal function
Poorly active against C. krusei and C. glabrata, it is best to check for susceptibilities and give 800mg/d
High F
Fluconazole utility
DOC for many susceptible fungal infections
Voriconazole AEs
Hepatotoxicity, rash, QT prolongation
Visual effects; tend to go away with continued use
Visual and auditory hallucinations
Sun sensitivity
Drug interactions (moderate inhibitor CYP2C9 and CYP 3A4)
Voriconazole important facts
Contraindicated in CrCl < 50 in IV; can use oral
Eliminated hepatically and not useful for treatment of candiduria
Utility of Voriconazole
DOC for invasive aspergillosis
Posaconazole AEs
Hepatotoxicity, rash
GI disturbances
QT prolongation
Posaconazole DDIs
Strong inhibitor of CYP3A4
Posaconazole important facts
Delayed release tablets and oral suspension dosing is not interchangedable
Oral: take with food to increase absorption
Posaconazole utility
PO tabs, suspension and IV: prophylaxis of candida and aspergillus in high risk patients
PO suspension: oropharyngeal candidiasis refractory or ristant to fluconazole/itraconazole
Isavuconazole AEs
Hepatotoxicity
Isavuconazole DDIs
Substrate of CYP3A4, inhibitor of CYP 4A4, P-gp, and organic cation transporter 2 (OCT 2)
Isavuconazole important facts
Supplied as a prodrug
Available as IV injection and PO capsules
Can be taken w/ or w/out food
Very broad spectrum
Very long t1/2; extensive loading dose regimen
Isavuconazole utility
treatment of invasive mold infections
Isavuconazole loading dose regimen
q8h x 48h then q24h
Echinocandins MOA
inhibit the synthesis of beta-1,3-glucan, a component of the fungal cell wall
Echinocandins
Capsofungin
Micafungin
Anidulafungin
Echinocandin good spectrum
C. albicans C. tropicalis C. lusitaniae C. galbrata*** C. krusei*** Aspergillus spp.*** C. parasilosis
Echinocandin moderate spectrum
Mucorales, in combo with ampho b
Echinocandin poor spectrum
Most non-aspergillus moulds
Cryptococcus neoformans
Echinocandin AEs
Mild histamine-mediated infusion-related reactions (not common; just slow down infusion rate)
Hepatotoxicity (rare)
Echinocandin important facts
No oral formulation yet
Differences among the echinocandins are minor and mostly PK
Capsofungin and micafungin are eliminated by non-CYP450 metabolism
Anidulafungin degrades in the plasma and avoids hepatic metabolism
Echinocandin DDIs
Minor
Be cautious when using caspofungin with CsA or rifampin and micafungin with sirolimus
Echinocandin utility
Becoming the DOC for invasive candidiasis
Useful for treatment of invasive aspergillosis but do not have the level of evidence that voriconazole and amphotericin do